Package 42192-626-16

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 42192-626-16
Digits Only 4219262616
Product NDC 42192-626
Product ID 42192-626_40422b8d-3f5d-6590-e063-6394a90a1532
Description

473 mL in 1 BOTTLE (42192-626-16)

Marketing

Marketing Status
Marketed Since 2023-10-09
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "40422b8d-3f5d-6590-e063-6394a90a1532", "openfda": {"upc": ["0342192626164"], "unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["56999559-274e-44ea-a317-29366fdca908"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (42192-626-16)", "package_ndc": "42192-626-16", "marketing_start_date": "20231009"}], "brand_name": "Pyridostigmine Bromide", "product_id": "42192-626_40422b8d-3f5d-6590-e063-6394a90a1532", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "42192-626", "generic_name": "pyridostigmine bromide", "labeler_name": "Acella Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "ANDA212405", "marketing_category": "ANDA", "marketing_start_date": "20231009", "listing_expiration_date": "20261231"}